Spending on and Use of Clinician-Administered Drugs in Medicare

IMPORTANCE: Medicare Part B drug expenditures have increased in recent years. This trend is likely to persist given the increased use and availability of biologics. OBJECTIVES: To assess the extent to which Medicare Part B spending growth was associated with changes in price vs quantity, and how the...

Descripción completa

Detalles Bibliográficos
Autores principales: Hyland, Megan F., Sachs, Rebecca M., Robillard, Lara, Hayford, Tamara B., Bai, Ge
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2023
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10492179/
https://www.ncbi.nlm.nih.gov/pubmed/37682554
http://dx.doi.org/10.1001/jamahealthforum.2023.2941

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10492179/
https://www.ncbi.nlm.nih.gov/pubmed/37682554
http://dx.doi.org/10.1001/jamahealthforum.2023.2941

Ejemplares similares